Eric dEsparbes - 15 Nov 2022 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role
Chief Financial Officer
Signature
/s/ Will Pridgen, Attorney-in-Fact for Eric d'Esparbes
Issuer symbol
BIORQ
Transactions as of
15 Nov 2022
Net transactions value
-$1,402
Form type
4
Filing time
16 Nov 2022, 20:48:01 UTC
Previous filing
16 Aug 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Tax liability $1,402 -5,194 -0.73% $0.2700 710,122 15 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 10,474 vested restricted stock units on November 15, 2022.
F2 Includes 6,887 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2021.